‘A jury of 10 men and two women was selected Tuesday to hear the nation’s fourth Vioxx trial, a lawsuit filed in south Texas by the family of an older man who died five years ago after battling heart disease for more than two decades.
Among those who were dismissed from the jury pool were a […]
‘A Food and Drug Administration advisory panel said Monday that GlaxoSmithKline’s fat-blocking drug Xenical is generally safe and should be sold without prescription, paving the way for it to become the first FDA-approved weight-loss drug available over-the-counter.
The panel of external advisors voted 11-3 to recommend the agency make a low-dose version of the drug available […]
‘Research and Markets (http://www.researchandmarkets.com/reports/c31192) has announced the addition of the Espicom Business Intelligence Ltd report: Bangladesh Pharmaceutical Market Intelligence Report to their offering.
World Pharmaceutical Markets country reports are ideal for executives wanting to understand the key drivers in Pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook […]
‘Marking something of a breakthrough in medical technology is a recent invention called the ‘Malaria Monitor’ wristwatch, designed to alert wearers of a dangerous presence of the disease in the blood.
According to reports carried by Reuters, e wristwatch is said to work by pricking the watch wearer’s wrist with a tiny needle and testing the […]
‘Healthcare company Australian Pharmaceutical Industries Ltd (ASX:API) has enjoyed a strong December trading period, thanks in part to a revitalised promotional program.
API today announced that sales at its retail division grew 25.4 per cent in December compared to the same period last year.
Feedback from pharmacists in the Soul Pattinson and Chemworld brands suggested that a […]
‘Pfizer Inc. is paying $1.3 billion to a French company for the global marketing rights to inhaled human insulin.
Sanofi-aventis SA formed an alliance in 1998 with Pfizer and another company to develop, make and sell the substance, known as Exubera, the first inhalable, non-injectable insulin medicine for treatment of diabetes Type-1 and Type-2.’
Read more at […]
‘Pfizer Inc., the world’s largest drug company, is struggling with a big problem: a growing campaign by employers and insurers to drive patients toward cheap generics.
Investors and the company have long known that generic copies would pummel several of Pfizer’s top drugs that are losing patent protection. But in a new twist, generic versions of […]
‘In an effort to prevent counterfeiting, Pfizer Inc. said it has started to ship Viagra bottles in the U.S. that feature radio chips under the labels. Pharmacists with the proper equipment can read the chip and check the electronic product code stored on it in order to ensure that the product is genuine.
Viagra, a prescription […]
‘Makers of generic drugs are gearing up for a big year as blockbuster brand-name medicines such as Zocor, Zoloft, Pravachol and Ambien are set to lose U.S. patent protection.
But analysts caution that stocks in producers of cheaper versions of those drugs are not sure bets.
Read more at Generic-Drug Makers Face a Big Year
‘Gov. Arnold Schwarzenegger on Monday urged the federal government to modify laws so Americans could safely import affordable prescription drugs from Canada and other countries.
It was a curious move, some said, because his call for federal legislation resembles proposed state legislation that he vetoed the past two years.
Assemblyman Dario Frommer, D-Glendale, who wrote the vetoed […]